Table-III.
Antimicrobial sensitivity patterns of microbial isolates
| Antimicrobial agent |
Pseudomonas aeruginosa
|
Non-aeruginosa Pseudomonas
|
Staphylococcus aureus
|
Methicillin-resistant Staphylococcus aureus
|
||||
|---|---|---|---|---|---|---|---|---|
|
n (%)
|
n (%)
|
n (%)
|
n (%)
|
|||||
| S | R | S | R | S | R | S | R | |
| AMC | 38 (31.40%) | 83 (68.60%) | 9 (36%) | 16 (64%) | 72 (67%) | 36 (33%) | 0 | 42 (100%) |
| OB | ---- | ---- | ---- | ---- | 66 (61%) | 42 (39%) | 0 | 42 (100%) |
| TZP | 110 (90.91%) | 11 (9.09%) | 22 (88%) | 3 (12%) | 76 (70%) | 32 (30) | 17 (40%) | 25 (60%) |
| CTX | 29 (23.97%) | 92 (76.03%) | 6 (24%) | 19 (76%) | ---- | ---- | ---- | ---- |
| CXM | 10 (8.26%) | 111 (91.7%) | 5 (20%) | 20 (80%) | ---- | ---- | ---- | ---- |
| CPO | 58 (47.93%) | 63 (52.07%) | 18 (72%) | 7 (28%) | 35 (32%) | 73 (68%) | 1 (2%) | 41 (98%) |
| SCF | 107 (88.43%) | 14 (11.57%) | 23 (92%) | 2 (09%) | 62 (57%) | 46 (43%) | 8 (19%) | 34 (81) |
| VA | ---- | ---- | ---- | ---- | 108 (100%) | 0 | 108 (100%) | 0 |
| ATM | 95 (78.51%) | 26 (21.49%) | 16 (64%) | 9 (36%) | ---- | ---- | ---- | ---- |
| IPM | 121 (100%) | 0 | 25 (100%) | 0 | 97 (90%) | 11 (10%) | 34 (81%) | 8 (19%) |
| CN | 68 (56.2%) | 53 (43.80%) | 16 (64%) | 9 (36%) | ---- | ---- | ---- | ---- |
| TOB | 68 (56.2%) | 53 (43.80%) | 16 (64%) | 9 (36%) | ---- | ---- | ---- | ---- |
| AK | 98 (80.99%) | 23 (19.01%) | 21 (84%) | 4 (16%) | 64 (59%) | 44 (41%) | 14 (33%) | 28 (67) |
| E | ---- | ---- | ---- | ---- | 19 (18%) | 89 (82%) | 1 (2%) | 41 (98%) |
| CLR | ---- | ---- | ---- | ---- | 32 (30%) | 76(70%) | 3 (7%) | 39 (93%) |
| DA | ---- | ---- | ---- | ---- | 55 (51%) | 53 (49%) | 10 (24%) | 32 (76%) |
| CIP | 79 (65.29%) | 42 (34.71%) | 16 (64%) | 9 (36%) | 43 (40%) | 65 (60%) | 3 (7%) | 39 (93) |
| C | ---- | ---- | ---- | ---- | 13 (12%) | 95 (88%) | 3 (7%) | 39 (93%) |
| SXT | 19 (15.70%) | 101 (84.30) | 7 (28%) | 18 (72%) | 33 (31%) | 75 (69%) | 7 (17%) | 35 (83%) |
| FOS | ---- | ---- | ---- | ---- | 32 (30%) | 76(70%) | 7 (17%) | 35 (83%) |
| FD | ---- | ---- | ---- | ---- | 26 (24%) | 82 (76%) | 7 (17%) | 35 (83%) |
| DO | ---- | ---- | ---- | ---- | 64 (59%) | 44 (41%) | 23 (55%) | 19 (45%) |
S = sensitive, R = resistant, AMC = clavulanic Acid, OB = cloxacillin, TZP = piperacillin/ tazobactam,
CTX = cefotaxime, CXM = cefuroxime, CPO = cefpirome, SCF = sulbactam-cefoperazone,
VA = vancomycin, ATM = aztereonam, IPM = imipenem, CN = gentamicin, TOB = tobramycin,
AK = amikacin, E = erythromycin, CLR = clarithromycin, DA = clindamycin, CIP = ciprofloxacin,
C = chloramphenicol, SXT = sulphamethethoxazole, FOS = fosfomycin, FD = fusidic acid,
DO = doxycycline, Data presented as n (%).